Tel: (857) 239-0968 / (617) 419-7131
Home > c-Kit
Cat.No. Product Name Information Area
T4332 DCC-2618 DCC-2618 is a potent inhibitor of c-Kit and c-Met with IC50s of <200 nM. Others
T3452 ISCK03 ISCK03 is a specific SCF/c-Kit inhibitor. Immunology
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fo... Cancer
T2624 OSI-930 OSI-930 is a potent inhibitor of Kit, KDR and CSF-1R with IC50 of 80 nM, 9 nM and 15 ... Cancer
T2620 G-749 G-749 is a novel and potent FLT3 inhibitor with IC50 of 0.4 nM, 0.6 nM and 1 nM for F... Cardiovascular System
T2609 Masitinib Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/80... Cancer
T2582 Apatinib Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM. Cancer
T2516 Amuvatinib(MP470) Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also ... Cancer
T2446 KI8751 Ki8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM, >40-fold se... Cancer
T2115 Pexidartinib Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inh... Cancer
T2070 CEP-32496 CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/3... Other
T1925 PLX647 PLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respe... Cancer
T1830 BX795 BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM, 140- and 1600-fold m... Other
T1667 Tandutinib Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 μM, also i... Cancer
T1621 Imatinib Mesylate Imatinib mesylate is a tyrosine kinase inhibitor IC50 value of 100 nM, 100 nM, 600 nM... Cancer
T1452 Axitinib Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth f... Cancer
T1448 Dasatinibhot Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved f... Cancer
T0374L Sunitinib Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with ... Cancer
T0374 Sunitinib Malate Potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor. Also inhibits cellular recep... Cancer